Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Immuno-inflammation
Page 3
Immuno-inflammation
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID
Firstwordpharma News
-
February 22, 2019
Immuno-inflammation
Certolizumab Offers 2-Year Durable Response in Treating Plaque Psoriasis: Presented at AAD
Immuno-inflammation
Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn’s & Colitis Congress
Immuno-inflammation
DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
Immuno-inflammation
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis
Immuno-inflammation
Janssen Presents New Four-Year TREMFYA (guselkumab) Data Demonstrating Maintained Rates of...
Firstwordpharma News
-
October 17, 2019
0
Immuno-inflammation
Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in...
Firstwordpharma News
-
February 18, 2019
0
Immuno-inflammation
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate...
Firstwordpharma News
-
December 9, 2019
0
Immuno-inflammation
Marker Therapeutics to Present at the 2018 Tumor Targeted Lymphocytes Summit
Biospace News
-
December 6, 2018
0
Immuno-inflammation
Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial
Biospace News
-
January 3, 2020
0
1
2
3
4
...
6
Page 3 of 6
- Advertisement -
MOST POPULAR
Tyra Biosciences Raises $50 Million to Focus on Cancer Drug Resistance
January 13, 2020
New drug added to PBS to help treat Australia’s deadliest cancer...
February 26, 2020
Data scientists ID potential vulnerabilities in the COVID-19 virus
February 17, 2020
Novartis sells US rights to cancer drug Proleukin to Clinigen for...
February 13, 2019
Load more
HOT NEWS
Phase II
GemVax announced phase II results of GV1001 for Alzheimer’s disease treatment...
Deals
Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing...
Commercial
Chi-Med to Announce 2019 Half-Year Financial Results
Others
U.S. Drug Spending Expected to Increase This Year and in Years...
